CSIMarket Company Name, Ticker, Industry, else..
 
Arqule Inc  (ARQL)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 120
 Employees -
 Revenues (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) -39
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Arqule Inc is a biopharmaceutical company focused on developing innovative therapeutics to treat patients with cancer and other diseases. The company's pipeline includes small molecule drugs targeting key signaling pathways involved in disease progression. Arqule's lead product candidate is a precision medicine called derazantinib, which is being studied for the treatment of certain types of intrahepatic cholangiocarcinoma (bile duct cancer) and other solid tumors. The company also has a collaboration agreement with other pharmaceutical companies to develop and commercialize additional therapies. Arqule's aim is to improve patient outcomes and make a significant impact in the field of oncology and beyond.




   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 8.38
Working Capital Ratio 8.57
Leverage Ratio (MRQ) 0.17
Total Debt to Equity 0.1
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.35 $
Revenues (TTM) 0.04 $
Cash Flow (TTM) 0.03 $
Cash 1.04 $
Book Value 1.27 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.03

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -5420.67 %
Net Margin (MRQ) -5162.98 %
Net Cash Flow Margin (MRQ) -43004.33 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.